Literature DB >> 17077106

Occupational exposure during application and removal of antifouling paints.

Ingrid Links1, Katinka E Van Der Jagt, Yvette Christopher, Marc Lurvink, Jody Schinkel, Erik Tielemans, Joop J Van Hemmen.   

Abstract

Exposure data on biocides are relatively rare in published literature, especially for secondary exposure. This is also the case for antifouling exposure. Therefore, a field study was carried out measuring exposure to antifouling paints. Both primary exposure (rolling and spraying) and secondary exposure (during sand blasting) were studied. Exposure during rolling was measured in boatyards where paints containing dichlofluanid (DCF) were applied. Spraying was measured in dockyards (larger than boatyards) where paints containing copper were applied. Furthermore, during sand blasting the removal of old paint layers containing copper was measured. A total of 54 datasets was collected, both for inhalation and dermal exposure data. For paint and stripped paint bulk analyses were performed. The following values are all arithmetic means of the datasets. Inhalation of copper amounted to 3 mg m-3 during spraying and to 0.8 mg m-3 during sand blasting. Potential body exposure loading amounted to 272 mg h-1 copper during spraying and 33 mg h-1 during sand blasting. For dichlofluanid the inhalation exposure loading was 0.14 mg m-3 during rolling, whereas the potential body exposure loading was 267 mg h-1 and potential hand exposure loading 277 mg h-1. The results for primary exposure compare well to the very few public data available. For the secondary exposure (sand blasting) no comparable data were available. The present study shows that the exposure loading should be considered more extensively, including applicable protective gear. In this light the findings for the potmen during sand blasting suggest that personal protective equipment should be (re)considered carefully.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077106     DOI: 10.1093/annhyg/mel074

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  8 in total

1.  The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels.

Authors:  Robert M Sargis; Brian A Neel; Clifton O Brock; Yuxi Lin; Allison T Hickey; Daniel A Carlton; Matthew J Brady
Journal:  Biochim Biophys Acta       Date:  2012-02-23

2.  Dietary exposure to the endocrine disruptor tolylfluanid promotes global metabolic dysfunction in male mice.

Authors:  Shane M Regnier; Andrew G Kirkley; Honggang Ye; Essam El-Hashani; Xiaojie Zhang; Brian A Neel; Wakanene Kamau; Celeste C Thomas; Ayanna K Williams; Emily T Hayes; Nicole L Massad; Daniel N Johnson; Lei Huang; Chunling Zhang; Robert M Sargis
Journal:  Endocrinology       Date:  2014-12-23       Impact factor: 4.736

3.  The endocrine disrupting chemical tolylfluanid alters adipocyte metabolism via glucocorticoid receptor activation.

Authors:  Brian A Neel; Matthew J Brady; Robert M Sargis
Journal:  Mol Endocrinol       Date:  2013-01-22

4.  GuLF DREAM: A Model to Estimate Dermal Exposure Among Oil Spill Response and Clean-up Workers.

Authors:  Melanie Gorman Ng; John W Cherrie; Anne Sleeuwenhoek; Mark Stenzel; Richard K Kwok; Lawrence S Engel; Jennifer M Cavallari; Aaron Blair; Dale P Sandler; Patricia Stewart
Journal:  Ann Work Expo Health       Date:  2019-07-23       Impact factor: 2.179

5.  Induction of SCEs and DNA fragmentation in bovine peripheral lymphocytes by in vitro exposure to tolylfluanid-based fungicide.

Authors:  Katarína Siviková; Ján Dianovsky; Beáta Holecková
Journal:  Genet Mol Biol       Date:  2011-03-01       Impact factor: 1.771

6.  Diet-dependence of metabolic perturbations mediated by the endocrine disruptor tolylfluanid.

Authors:  Shane M Regnier; Andrew G Kirkley; Daniel Ruiz; Wakanene Kamau; Qian Wu; Kurunthachalam Kannan; Robert M Sargis
Journal:  Endocr Connect       Date:  2017-11-29       Impact factor: 3.335

7.  Development and In Vitro Validation of Antibacterial Paints Containing Chloroxylenol and Terpineol.

Authors:  Micaela Machado Querido; Ivo Paulo; Sriram Hariharakrishnan; Daniel Rocha; Nuno Barbosa; Diogo Gonçalves; Rui Galhano Dos Santos; João Moura Bordado; João Paulo Teixeira; Cristiana Costa Pereira
Journal:  Toxics       Date:  2022-06-21

8.  Impact of Tralopyril and Triazolyl Glycosylated Chalcone in Human Retinal Cells' Lipidome.

Authors:  Cátia Vilas-Boas; Logan Running; Daniela Pereira; Honorina Cidade; Marta Correia-da-Silva; Gunes Ekin Atilla-Gokcumen; Diana S Aga
Journal:  Molecules       Date:  2022-08-17       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.